I’m not sure how CHM could speed up their trials. 1101 is still in dose escalation which will finish this year and has seen stable disease rates in 70% of those treated. I think that’s a bit of a win already to give people with GBM a little more time.
The combo trial has only just started and it’s already shown efficacy in blood cancer. I’m not sure what you expect.
I’m not sure how CHM could speed up their trials. 1101 is still...
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.002(11.1%) |
Mkt cap ! $17.25M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $26.18K | 1.372M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 736556 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1462067 | 5 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CHM (ASX) Chart |